688626 翔宇医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入537,0306.00%743,531744,810488,529523,496
减:营业总成本520,27116.80%656,508529,660414,020358,786
    其中:营业成本176,2004.93%242,253233,715164,762166,316
               财务费用(9,929)-39.26%(23,715)(29,813)(26,644)(23,977)
               资产减值损失(4,269)16.49%(9,189)(12,117)(5,952)(2,777)
公允价值变动收益------------
投资收益6,135340.21%1,4019,29313,65212,125
    其中:对联营企业和合营企业的投资收益4,9495,396.33%62(540)(2,062)(1,840)
营业利润45,578-42.98%108,513244,629135,463224,059
利润总额44,305-44.06%107,235244,031132,992222,721
减:所得税费用2,398-58.81%4,38215,7179,69723,182
净利润41,907-42.89%102,853228,314123,295199,539
减:非控股权益(2,074)6,454.66%(90)1,171(2,175)(2,359)
股东净利润43,982-40.09%102,944227,143125,470201,897

市场价值指针
每股收益 (元) *0.290-38.30%0.6601.4400.7901.350
每股派息 (元) *----0.2400.5300.2400.380
每股净资产 (元) *12.6670.05%12.74213.06812.04712.094
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容